Filings Intelligence
Company filings profile · CIK 0001994702

Kyverna Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Kyverna Therapeutics, Inc. (KYTX): 7 filings in the last 90 days vs 28 in the prior 90 (filing-velocity cooling ↓ · 0.25×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 24, 2026. Source-linked, daily-refreshed.

Material 8-K events — Kyverna Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 24, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Aug 11, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Jul 27, 2026Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits↗
Jul 9, 2026Entry into a Material Agreement; Financial Statements and Exhibits↗
Jun 2, 2026Item 5.07; Financial Statements and Exhibits↗
May 18, 2026Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits↗
May 12, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
May 4, 2026Other Events; Financial Statements and Exhibits↗
Apr 22, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Apr 22, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Apr 20, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Mar 26, 2026Results of Operations (earnings); Financial Statements and Exhibits↗

Watch Kyverna Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Watch this company →See a sample alert

Insider transactions (Form 4 / 3 / 5)

FiledForm
May 29, 20264↗
May 29, 20264↗
May 29, 20264↗
May 29, 20264↗
May 29, 20264↗
May 20, 20264↗
May 20, 20263↗
May 6, 20264↗
May 6, 20263↗
Mar 17, 20264↗
Mar 17, 20264↗
Mar 17, 20264↗
Mar 4, 20263↗
Mar 4, 20264↗
Feb 26, 20264↗
Feb 26, 20263↗
Feb 11, 20263↗
Feb 11, 20264↗
Jan 14, 20264↗
Dec 22, 20254↗

Recent filings

FiledFormDetail
Sep 24, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 14, 2026SCHEDULE 13G/A ↗
Aug 11, 202610-Q 10-Q ↗
Aug 11, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Jul 29, 2026SCHEDULE 13G ↗
Jul 27, 20268-K Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jul 9, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits ↗
Jun 2, 20268-K Item 5.07; Financial Statements and Exhibits ↗
May 29, 20264 4 ↗
May 29, 20264 4 ↗
May 29, 20264 4 ↗
May 29, 20264 4 ↗
May 29, 20264 4 ↗
May 20, 20264 4 ↗
May 20, 20263 3 ↗
May 18, 20268-K Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits ↗
May 12, 202610-Q 10-Q ↗
May 12, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
May 6, 20264 4 ↗
May 6, 20263 3 ↗
May 4, 20268-K Other Events; Financial Statements and Exhibits ↗
Apr 22, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Apr 22, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Apr 20, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Apr 17, 2026144 ↗
Apr 14, 2026144 ↗
Apr 13, 2026ARS ARS ↗
Apr 13, 2026DEFA14A DEFA14A ↗
Apr 13, 2026DEF 14A DEF 14A ↗
Apr 7, 2026144 ↗
Apr 2, 2026EFFECT Item ; Item ; Item ↗
Apr 2, 2026424B5 424B5 ↗
Mar 31, 2026144 ↗
Mar 31, 2026CORRESP ↗
Mar 30, 2026UPLOAD ↗
Mar 26, 2026S-8 S-8 ↗
Mar 26, 2026S-3 S-3 ↗
Mar 26, 202610-K 10-K ↗
Mar 26, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Mar 17, 20264 4 ↗